Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.

NCT00828958 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Risperidone long-acting injectable

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.